EU approves Celltrion's COVID-19 antibody treatment

The European Union's drug agency has approved the COVID-19 antibody treatment by Celltrion Inc. This is a milestone for the South Korean pharmaceutical company as it will pave the way for the sale of the treatment in the region.

Highlights

• Treatment by Celltrion receives approval by European Union

• ....

Click here to read more

Tags : Celltrion, Rekirona, European Union, Approved, COVID-19, Antibody,

SHARE THIS ARTICLE

What are you searching for?

Healthcare

EU approves Celltrion's COVID-19 antibody treatment

Published On 12 Nov 2021 06:33 AM

Recent Posts

According to the White House, Biden was not exposed to the question regarding Israel's decision to postpone its ground invasion of Gaza.

Asia's leading graphite producer, China, will restrict exports of a crucial battery material.

Japan requests Google to reverse the names of contested islets in the East China Sea.

Israel Rectifies Greta Thunberg's Post Regarding Gaza By Stating, "Hamas Doesn't..."

"A great deal of suffering": Jews in Europe anticipate an increase in antisemitism in the wake of the Hamas attack.

Airport and Versailles evacuations are prompted by French arrests following bomb concerns.

A man who is charged with bringing firearms onto the grounds of the Wisconsin State Capitol has pleaded not guilty to the misdemeanor charge.

Jeju Shinhwa World provides customized staycations for all visitors.

The GSDF Osprey makes its maiden voyage to Okinawa.

Conflict between Israel and Hamas: India demands strict compliance with international humanitarian law

Relations between Israel and its Arab neighbors in the Middle East

Eight airports in France have received security notifications.

A prospective Biden visit to Israel is fraught with political and security obstacles.

Physicians vow to oppose the government's plan to increase medical school quotas.

The economy minister of Japan pays a visit to Yasukuni Shrine prior to the autumn festival.